ABSTRACT
Background Many countries around the world have developed mobile phone apps capable of supporting instantaneous contact tracing to control the Covid-19 pandemic. In France, a few people have downloaded and are using the StopCovid contact tracing app. Reasons for this low uptake are unexplored. Students in the health domain are especially concerned and their usage and opinions about the app can inform improvements and diffusion of StopCovid among young people.
Objective To investigate health-related students’ knowledge, attitudes, beliefs and practices about the StopCovid app.
Methods A field survey was conducted among 318 students at the health sciences campus of the University of Bordeaux, France, between September 25th and October 16th, 2020. Quota sampling method was used and descriptive statistics were performed.
Results A total of 77.3% (246/318) students had heard about the app, but only 11.3% (36/318) had downloaded it and 4.7% (15/318) were still using it at the time of the survey. Main reasons for not using the app were: belief that it was not effective given its limited diffusion (17.6%, 37/210), lack of interest (17.6%, 37/210) and distrust in data security and fear to be geo-located (15.7%, 33/210). Among those who had not heard about the app, after a brief description of its functioning and confidentiality policy, 52.7% (38/72) would use it. Participants reported that the main solution for increasing the use of the app would be a better communication (71.4%, 227/318).
Conclusion Even among health students, the contact tracing app was poorly used. Findings suggest that improved communication describing its advantages and simplicity of use, and clarifying false beliefs about the app could help improving significantly its uptake.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The i-Share team is currently supported by an unrestricted grant of the Nouvelle-Aquitaine Regional Council (Conseil Regional Nouvelle-Aquitaine) (grant Nr 4370420) and by the Bordeaux Initiatives d'excellence (IdEx) program of the University of Bordeaux (ANR-10-IDEX-03-02). The team has also received grants from Public Health France (Sante Publique France, contract Nr 19DPPP023-0) and the Nouvelle-Aquitaine Regional Health Agency (Agence Regionale de Sante Nouvelle-Aquitaine). The funding bodies were neither involved in the study design, or in the collection, analysis, or interpretation of the data.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The field survey was approved by the University of Bordeaux. The oral informed consent reassured students of the anonymous format of the survey and use of collected data for research purposes only.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
In this version, we added data about the quota sampling (Table 1) and new analyses to corroborate our results (first two paragraphs of the results).
Data Availability
All data generated or analysed during this study are included in this manuscript. The full dataset is available on reasonable request.
